The Effect of Tirzepatide on Food Intake in Humans
In this medfyle
Tirzepatide achieved greater weight loss than semaglutide and loss in body weight was mostly driven by fat mass loss. Even if clinically meaningful reductions in appetite and energy intake were seen with both tirzepatide and semaglutide, these effects could not completely explain the additional weight loss with tirzepatide.
This Medfyle was published more than two years ago. More recent Medfyle on this topic may now be available.
About this Medfyle
This is a summary of an oral session given at the ObesityWeek® 2022 and presented by:
Julia P. Dunn, MD
Eli Lilly and Company
Indianapolis, IN, USA
The content is produced by Infomedica. The presenting authors of the original session had no part in the creation of this conference summary.
